TVARDI THERAPEUTICS, INC. Increase (Decrease) in Other Operating Assets and Liabilities, Net
TVARDI THERAPEUTICS, INC. (TVRD) reported Increase (Decrease) in Other Operating Assets and Liabilities, Net of $108.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet · last filed 2025-03-11
- TVARDI THERAPEUTICS, INC. increase (decrease) in other operating assets and liabilities, net for the quarter ending 2023-12-31 was $0.00.
- TVARDI THERAPEUTICS, INC. increase (decrease) in other operating assets and liabilities, net for fiscal 2023 was $108.00K.
| Period end | Increase (Decrease) in Other Operating Assets and Liabilities, Net 3 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 9 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 12 month |
|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $108.00K 10-K · filed 2025-03-11 | |
| 2023-09-30 | $108.00K 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |